Page last updated: 2024-08-21

glycyrrhizic acid and HIV Coinfection

glycyrrhizic acid has been researched along with HIV Coinfection in 5 studies

Research

Studies (5)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's2 (40.00)18.2507
2000's2 (40.00)29.6817
2010's0 (0.00)24.3611
2020's1 (20.00)2.80

Authors

AuthorsStudies
Fando, AA; Fomenko, VV; Karpenko, LI; Komarova, NI; Maksyutov, RA; Pokrovsky, AG; Pyankov, OV; Rogachev, AD; Rudometova, NB; Salakhutdinov, NF; Shcherbakov, DN; Yarovaya, OI; Zaykovskaya, AV1
Gougeon, ML; Melki, MT; Saïdi, H1
Kobayashi, M; Li, XD; Pollard, RB; Suzuki, F; Yoshida, T1
Gohchi, K; Matsuda, J1
Aihara, M; Akutsu, Y; Imaizumi, M; Ishikawa, M; Mori, K; Sakai, H; Sawada, Y; Suzuki, S; Tada, K; Yokoyama, M1

Trials

1 trial(s) available for glycyrrhizic acid and HIV Coinfection

ArticleYear
Effects of glycyrrhizin (SNMC: Stronger Neo-Minophagen C) in hemophilia patients with HIV-1 infection.
    The Tohoku journal of experimental medicine, 1990, Volume: 162, Issue:2

    Topics: Acquired Immunodeficiency Syndrome; Adult; AIDS-Related Complex; Antigens, CD; Antigens, Differentiation, T-Lymphocyte; Antiviral Agents; CD4 Antigens; CD8 Antigens; Glycyrrhetinic Acid; Glycyrrhizic Acid; Hemophilia A; HIV Infections; HIV Seropositivity; Humans; Lymphocyte Activation; Lymphocytes; Male

1990

Other Studies

4 other study(ies) available for glycyrrhizic acid and HIV Coinfection

ArticleYear
Synthesis and In Vitro Study of Antiviral Activity of Glycyrrhizin Nicotinate Derivatives against HIV-1 Pseudoviruses and SARS-CoV-2 Viruses.
    Molecules (Basel, Switzerland), 2022, Jan-04, Volume: 27, Issue:1

    Topics: Animals; Antiviral Agents; Chlorocebus aethiops; COVID-19; COVID-19 Drug Treatment; Glycyrrhizic Acid; HeLa Cells; HIV Infections; HIV-1; Humans; In Vitro Techniques; SARS-CoV-2; Vero Cells; Virus Replication

2022
HMGB1-dependent triggering of HIV-1 replication and persistence in dendritic cells as a consequence of NK-DC cross-talk.
    PloS one, 2008, Volume: 3, Issue:10

    Topics: Antibodies; Cell Communication; Cells, Cultured; Cytokines; Dendritic Cells; Glycyrrhizic Acid; HIV Infections; HIV-1; HLA-DR Antigens; HMGB1 Protein; Humans; Killer Cells, Natural; Leukocyte Common Antigens; Models, Biological; Receptor Cross-Talk; Receptor for Advanced Glycation End Products; Virus Replication

2008
Inhibitory effect of glycyrrhizin on the neutrophil-dependent increase of R5 HIV replication in cultures of macrophages.
    Immunology and cell biology, 2009, Volume: 87, Issue:7

    Topics: Antiviral Agents; Cells, Cultured; Chemokine CCL2; Down-Regulation; Drug Evaluation, Preclinical; Glycyrrhizic Acid; HIV; HIV Infections; Humans; Interleukin-10; Macrophages; Neutrophil Activation; Neutrophils; Receptors, CCR5; Receptors, HIV; Virus Replication

2009
[Immunotherapy for HIV carrier].
    Nihon rinsho. Japanese journal of clinical medicine, 1993, Volume: 51 Suppl

    Topics: Carrier State; Ditiocarb; Drugs, Chinese Herbal; Glycyrrhetinic Acid; Glycyrrhizic Acid; HIV Infections; Humans; Immunotherapy; Inosine Pranobex; Lentinan; Poly I-C; Poly U

1993